Company: NIVFW
Filing Date: 2025-09-18
Form Type: F-1
Source: 0001213900-25-088927
Chunk: 254

Company: NewGenIvf Group Ltd
Filing Date: 2025-09-18
Form: F-1
Chunk 254
---
961 in additional net proceeds from the 2024 Debt Financing if all remaining Additional Notes in the aggregate
principal amount of $3,150,000 (together with the Fourth Tranche Note and Fifth Tranche Note,
the “Remaining Additional Notes”) issuable pursuant to the Securities Purchase Agreement are sold and (ii) the Series A Warrants
are increased by 10,157,580 assuming that (A) all Remaining Additional Notes are sold and (B) an Additional Share Price is equal to $1.3513
and (iii) all of the Warrants are exercised in full, based on the following assumptions (x) approximately $23,909,021 in net proceeds
are received from the exercise of the Series A Warrants, assuming that the Series A Warrants are exercised in full at an exercise price
of $1.8258 and the number of Ordinary Shares issuable upon exercise of the Series A Warrants equals 13,095,093, (y) approximately $1,485
in net proceeds are received from the exercise of the Series B Warrants, assuming that the Series B Warrants are exercised in full at
an exercise price of $0.020 per share, and (z) approximately $3,005,784 in net proceeds are received from the exercise of the Exchange
Warrants, assuming that the Exchange Warrants are exercised in full at an exercise price of $1.8258. The foregoing is subject to adjustment
as set forth in the respective Notes and Warrants, as applicable.

<div align='center'>II-3</div>

White Lion Equity Line of Credit

On November 21, 2024, the
Company entered into a Common Shares Purchase Agreement (the “White Lion Purchase Agreement”) with White Lion Capital, LLC
(“White Lion”) and a related Registration Rights Agreement (the “RRA”). Pursuant to the White Lion Purchase Agreement,
the Company has the right, but not the obligation, to require White Lion to purchase, from time to time, up to One Hundred Million Dollars
($100,000,000) in aggregate gross purchase price of newly issued Ordinary Shares, with an automatic increase to Three Hundred Million
Dollars ($300,000,000) upon any substantial M&A or Material Transaction (as defined in the White Lion Purchase Agreement) and a further
option to increase to Five Hundred Million Dollars ($500,000,000) after Two Hundred and Fifty Million Dollars ($250,000,000) has